Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ATHA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ATHA investment potential.

What is ATHA stock price today?

Get real-time ATHA stock price, historical data, and price charts on Financhill. Track ATHA performance with our advanced analysis tools.

Is ATHA a good investment?

Evaluate ATHA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ATHA stock?

To buy ATHA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ATHA?

View detailed market capitalization data and company valuation metrics for ATHA on our comprehensive analysis page.

What is the P/E ratio of ATHA?

Use our fundamental analysis tools to view ATHA P/E ratio and compare valuation metrics with industry peers.

What are ATHA earnings?

View ATHA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Athira Pharma, Inc. 10K Form

Buy

ATHA
Athira Pharma, Inc.

Last Price:

$6.92

Seasonality Move:

10.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATHA News And Ratings

See the #1 stock for the next 7 days that we like better than ATHA

ATHA Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-4.7M
Price / Cash Flow:	0
Annual Sales:	$6.79
Price / Book:	1.03

Profitability

EPS (TTM):	-7.55010
Net Income (TTM):	$-37.7M
Gross Margin:	$-970K
Return on Equity:	-95.01%
Return on Assets:	-74.22%

Athira Pharma, Inc. Earnings Forecast

Key Athira Pharma, Inc. Financial Ratios

Per Share Earnings over the last 7 years have been positive in 0 years.

Athira Pharma, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	ATHA
CUSIP:	04746L
Website:	athira.com

Debt

Debt-to-Equity Ratio:	0.03
Current Ratio:	9.7
Quick Ratio:	9.05

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

ATHA Technical Analysis vs Fundamental Analysis

Buy

Athira Pharma, Inc. (ATHA) is a Buy

Is Athira Pharma, Inc. a Buy or a Sell?

Athira Pharma, Inc. stock is rated a Buy

The current Athira Pharma, Inc. [ATHA] share price is $6.97. The Score for ATHA is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.